ID
2
Cancer Name
Breast Cancer
Main Grouping
Endocrine/Reproductive
Organ System
Breast, Lymph Nodes
Cell Origin
Epithelial (ductal/lobular)
Pathways Affected
Breast cancer involves extensive dysregulation across multiple oncogenic and tumor suppressor signaling networks. The PI3K/AKT/mTOR pathway is among the most frequently altered, with PIK3CA mutations present in approximately 40% of ER+ tumors; activation of this pathway promotes cell survival, suppresses apoptosis, and drives anabolic processes via mTORC1 signaling. HER2 overexpression activates both the MAPK/ERK cascade and PI3K/AKT axis, driving cell cycle progression, angiogenesis, and evasion of programmed cell death. Estrogen signaling through ERα promotes transcription of proliferative genes including cyclin D1 and c-Myc and feeds into PI3K and MAPK pathways through non-genomic mechanisms. The NF-κB pathway sustains inflammatory signaling and anti-apoptotic gene expression, while JAK/STAT signaling — particularly STAT3 — promotes cancer stem cell maintenance and immune evasion. The Wnt/β-catenin pathway contributes to stem cell renewal and epithelial-mesenchymal transition (EMT), which enables invasiveness and metastatic dissemination. VEGF-driven angiogenesis sustains tumor vascularization and is upregulated under hypoxic conditions mediated by HIF-1α. The p53 tumor suppressor pathway is compromised in a significant proportion of breast cancers, particularly TNBC, resulting in unchecked cell cycle progression and reduced apoptotic response. The TGF-β/SMAD pathway has a dual role, functioning as a tumor suppressor in early-stage disease and promoting EMT and metastasis in advanced disease. DNA repair pathways including homologous recombination, mediated in part by BRCA1 and BRCA2, are impaired in hereditary breast cancer subtypes. The Notch and Hedgehog signaling pathways are associated with cancer stem cell populations in TNBC. Autophagy modulation, oxidative phosphorylation reprogramming, and Nrf2-mediated antioxidant response are additional metabolic and stress-response pathways that influence tumor cell survival and therapeutic resistance. The one-carbon folate cycle and methionine/SAM cycle govern DNA methylation and epigenetic regulation of tumor suppressor gene expression, linking dietary folate and methyl-donor status to breast cancer gene silencing patterns.
Description
Breast cancer is the most commonly diagnosed malignancy among women worldwide and a leading cause of cancer-related mortality. It originates primarily in the ductal or lobular epithelial cells of the breast and spans a broad spectrum of subtypes defined by receptor expression status: estrogen receptor-positive (ER+), progesterone receptor-positive (PR+), human epidermal growth factor receptor 2-overexpressing (HER2+), and triple-negative breast cancer (TNBC), which lacks all three receptors. These molecular subtypes dictate biological behavior, clinical trajectory, and responsiveness to various interventions. ER+ tumors, the most prevalent subtype, are driven by estrogen signaling through ERα, which promotes cell proliferation and survival; HER2+ tumors are characterized by amplification of the ERBB2 gene on chromosome 17, leading to constitutive activation of downstream growth pathways; TNBC is the most aggressive subtype and is associated with a basal-like phenotype, higher rates of genomic instability, and a less favorable prognosis.
Epidemiological studies have consistently reported inverse correlations between dietary fruit and vegetable consumption and breast cancer incidence. Foods rich in isoflavones, lignans, glucosinolates, polyphenols, carotenoids, and fiber have been examined across multiple observational and mechanistic research frameworks. Soy-derived isoflavones, primarily genistein and daidzein, exert modulatory activity on estrogen receptors, with genistein inhibiting invasion of MCF-7 and MDA-MB-231 breast carcinoma cells and suppressing matrix metalloproteinase-9 expression. Flaxseed contains secoisolariciresinol diglucoside (SDG), which is metabolized by gut flora into enterolactone and enterodiol — mammalian lignans with antiestrogen activity and structural similarity to estrogen that enable competitive receptor binding and reduction of estrogenic stimulation of cancer cells.
Cruciferous vegetables provide glucosinolates that are hydrolyzed into bioactive isothiocyanates, including sulforaphane and indole-3-carbinol. Sulforaphane has been shown to modulate epigenetic mechanisms including DNA methylation and histone acetylation, reduce cancer stem cell populations, and induce apoptosis in multiple breast cancer cell lines. Ellagic acid, found in pomegranates, berries, and walnuts, inhibits MCF-7 cell proliferation by arresting the cell cycle at G0/G1 phase and modulating TGF-β/SMAD3 signaling. EGCG from green tea inhibits breast cancer cell growth and metastasis through antioxidant activity and suppression of cell cycle progression, while curcumin from turmeric modulates NF-κB, Nrf2, and apoptotic pathways to suppress tumor cell proliferation. Mushroom-derived beta-glucans, particularly from maitake and shiitake, demonstrate immunomodulatory activity through stimulation of macrophages, natural killer cells, and cytokine production including interleukin-1, interleukin-2, and G-CSF. A phase I/II clinical trial evaluating maitake extract in postmenopausal breast cancer patients confirmed immunological effects and safety across all dosage cohorts.
Plant-Based Description
A whole-food plant-based dietary pattern provides phytochemicals, fiber, polyphenols, phytoestrogens, and isothiocyanates that have been studied for their roles in modulating estrogen metabolism, reducing oxidative stress, suppressing pro-inflammatory signaling, and supporting immune surveillance in the context of breast cancer. Epidemiological data indicate that populations with consistently high consumption of plant-derived foods — including cruciferous vegetables, legumes, whole grains, berries, and green tea — show differences in breast cancer incidence and recurrence patterns compared to populations consuming lower quantities. Plant lignans are converted by gut microbiota into bioactive enterolignans, which interact with estrogen receptor pathways. Cruciferous glucosinolate metabolites activate phase II detoxification enzymes, promote carcinogen clearance, and have been shown to influence epigenetic regulation of tumor suppressor genes. The diversity of bioactive compounds across different plant food categories enables multi-pathway engagement that addresses several hallmarks of breast cancer biology simultaneously.
Plant Chemistry Detail
The phytochemical composition of plant foods relevant to breast cancer spans several structural and functional classes.
Isoflavones from soybeans — genistein, daidzein, and glycitein — are structurally analogous to 17β-estradiol and bind both ERα and ERβ with differential affinities, enabling competitive interference with endogenous estrogen signaling.
Lignans from flaxseeds, primarily secoisolariciresinol and matairesinol, are converted by intestinal bacteria to enterolactone and enterodiol, which exert antiestrogen and antioxidant activity.
Glucosinolates in cruciferous vegetables (broccoli, cabbage, Brussels sprouts, kale) are hydrolyzed by myrosinase to sulforaphane and indole-3-carbinol; sulforaphane activates Nrf2-mediated antioxidant response and epigenetically represses cancer stem cell markers, while indole-3-carbinol and its metabolite DIM modulate estrogen hydroxylation pathways and ERα expression.
Curcuminoids from turmeric — curcumin, demethoxycurcumin, and bisdemethoxycurcumin — inhibit NF-κB, downregulate COX-2, and induce apoptosis through modulation of Bcl-2 family proteins.
EGCG from green tea is a catechin that inhibits VEGF receptor signaling and topoisomerase activity and induces G1 cell cycle arrest in breast cancer cell lines.
Ellagitannins from pomegranates and berries, including punicalagin, are metabolized to urolithin A in the colon and exert cell cycle arrest via TGF-β/SMAD3.
Anthocyanins from berries and dark grapes modulate NF-κB and MAPK/ERK signaling.
Quercetin from apples, onions, and berries has pro-apoptotic and anti-proliferative effects in ER-negative breast cancer cell models.
Allicin and diallyl sulfides from garlic inhibit aromatase activity, which catalyzes androgen-to-estrogen conversion relevant to ER+ breast cancer.
Beta-carotene and lycopene from carrots, sweet potatoes, and tomatoes regulate oxidative stress and modulate apoptotic signaling.
Mushroom-derived beta-glucans, particularly from maitake and shiitake, activate macrophages, NK cells, and dendritic cells, stimulating cytokine production including interleukins and G-CSF to enhance immune surveillance.
Nutritional Focus
A plant-based dietary pattern for breast cancer research emphasizes isoflavone-rich legumes — particularly soybeans and edamame — as sources of genistein and daidzein; cruciferous vegetables for glucosinolate-derived sulforaphane and indole-3-carbinol; flaxseeds as the primary dietary lignan source yielding gut-metabolized enterolactone and enterodiol; berries and pomegranate for ellagic acid, anthocyanins, and quercetin; green tea for EGCG; turmeric for curcuminoids; and mushrooms, especially maitake and shiitake, for immunomodulatory beta-glucan polysaccharides. Dietary fiber from whole grains and legumes supports estrogen clearance by reducing intestinal beta-glucuronidase activity, which decreases reabsorption of conjugated estrogens from the gut and reduces circulating estrogen levels.
Research Notes
A systematic review and meta-analysis (PMC10868383, 32 studies) found soy isoflavone intake was associated with a 26% reduced risk of recurrence (HR=0.74) among breast cancer survivors, with the greatest effect at 60 mg/day in postmenopausal and ER+ populations, and serum enterolactone was inversely associated with cancer-specific mortality (HR=0.72). A phase I/II clinical trial (PMC3751581) in 34 postmenopausal breast cancer patients administered maitake polysaccharide extract and confirmed immunological modulation with no dose-limiting toxicity. PMC5955106 documented direct antitumoral and antimetastatic activity of Maitake D-Fraction in triple-negative breast cancer cell lines. PMC9182524 reviewed twenty years of evidence on natural products against breast cancer, documenting that phytochemical classes inhibit PI3K/AKT/mTOR, NF-κB, MAPK/ERK, Notch, and EMT pathways. PubMed 25647396 demonstrated ellagic acid arrests MCF-7 breast cancer cells at G0/G1 phase via TGF-β/SMAD3. PMC12293898 compiled mechanistic evidence for ellagic acid, ferulic acid, curcumin, genistein, EGCG, and carotenoids in breast cancer cell line models.
Notes Visibility
show
Key Foods
Soybeans (Mature, Cooked), Flax Seeds (Whole, Raw), Broccoli, Kale, Green Cabbage, Yellow Onion, Garlic, Cauliflower, Black Lentils, Green Lentils, Red Lentils, Brown Lentils, Chickpeas, Almond (Raw), English Walnut (Raw), Chia Seeds (Whole, Dried), Shiitake (Raw), Maitake (Raw), Oats (Cooked), Brown Rice (Cooked), Quinoa (Cooked), Amaranth (Cooked), Mango, Blueberry, Strawberry, Blackberry, Pineapple, Banana, Orange, Grapefruit, Kiwi, Papaya, Lemon, Leek,Avocado,Artichoke,Radish,Tangerine, Red Onion
Linked Nutrients
Folate (vitamin B9) supports one-carbon metabolism and DNA methylation fidelity, with inadequate folate associated with aberrant methylation of tumor suppressor gene promoters in breast tissue.
Vitamin C functions as a direct antioxidant and supports collagen synthesis and iron absorption from plant sources, which modulates oxidative stress in tumor microenvironments.
Vitamin E as a fat-soluble antioxidant protects cell membranes from lipid peroxidation and may reduce oxidative DNA damage.
Vitamin K1 activates carboxylation-dependent proteins and has been examined in the context of cell cycle regulation.
Selenium is incorporated into selenoproteins including glutathione peroxidase and thioredoxin reductase, which govern hydrogen peroxide detoxification and redox balance in breast tissue.
Zinc is a structural cofactor in zinc finger transcription factors including tumor suppressor p53, and adequate zinc status supports DNA repair fidelity.
Magnesium functions as a cofactor for enzymatic reactions involved in DNA replication and repair. Calcium and potassium regulate membrane potential and cellular signaling across growth factor receptor systems.
